# FDA Inspection 807392 - LEK d.d. - October 12, 2012

Source: https://www.keypedia.com/records/fda_inspections/lek-dd/e2095b99-b2a8-4322-8739-7d75f9e91f86
Source feed: FDA_Inspections

> FDA Inspection 807392 for LEK d.d. on October 12, 2012. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 807392
- Company Name: LEK d.d.
- Inspection Date: 2012-10-12
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1271780 - 2022-11-24](https://www.keypedia.com/records/fda_inspections/lek-dd/46b25020-1a2a-4cb1-b232-61268d3d464c)
- [FDA Inspection 1123872 - 2019-08-30](https://www.keypedia.com/records/fda_inspections/lek-dd/80c36573-f200-4140-b020-5812f5b7518a)
- [FDA Inspection 945705 - 2015-09-25](https://www.keypedia.com/records/fda_inspections/lek-dd/4e2649ea-18b4-4586-a466-23bb930088c2)
- [FDA Inspection 548049 - 2008-11-11](https://www.keypedia.com/records/fda_inspections/lek-dd/4362b622-32e3-49ea-a7c9-368990e450d2)

Company: https://www.keypedia.com/companies/lek-dd/49b1b882-f72b-4d83-b4b6-d6e117f97274

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c